Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Nadir Arber
44 years of experience
accreditations :
Clinic is certified :
| Israel | Turkey | Austria | |
| Selective Apheresis | - | from $1,550 | - |
| Curcumin IV Therapy | - | from $350 | from $350 |
Prof. Arber is a leading gastroenterologist with a focus on cancer prevention. He has pioneered research linking chronic inflammation to gastrointestinal cancers.
A top Israeli liver expert with over 61 years of experience of experience, Dr. Shebolet heads the Liver Unit at Sourasky Medical Center (Ichilov).
Prof. Maharshak Nitzan is a leading specialist in ulcerative colitis and currently heads the Department of Inflammatory Bowel Diseases at Tel Aviv Medical Center.
A pioneer in Israel's gastroenterology field – Dr. Santo was the first to use interventional ultrasound and co-founded a major European endoscopy society. He leads the Gastroenterology Department at Sourasky Medical Center.
Israel offers advanced ulcerative colitis treatments ranging from targeted biologics to innovative botanical therapies. Patients access specialized care at JCI-accredited centers like Sourasky Medical Center and Hadassah. Protocols emphasize early escalation to biological agents and unique options like curcumin intravenous therapy or selective apheresis.
Bookimed Expert Insight: Data shows a high concentration of world-recognized gastroenterology leadership in Tel Aviv. Specialists like Prof. Nadir Arber and Prof. Zamir Halperin at Sourasky Medical Center hold over 60 combined years of experience. This expertise allows clinics to offer niche treatments like curcumin IV therapy that are rarely available in standard European protocols.
Patient Consensus: Patients note that Israeli doctors often move to biologics quickly to stop flares. They emphasize the importance of tracking side effects closely since many people need to switch medications within the first year.
Israel treats ulcerative colitis with innovative botanical combinations, advanced gene therapy research, and bacteriotherapy. Leading centers like Sourasky Medical Center and Hadassah Medical Center utilize CurQD, mesenchymal stem cell infusions, and selective apheresis. JCI-accredited facilities offer these therapies to patients who fail standard biological treatments.
Bookimed Expert Insight: While many countries focus on pharmaceutical biologics, Israel leads in integrating botanical protocols into clinical practice. Our data shows specialized units like the Bacteriotherapies Clinic at Sourasky Medical Center offer research-backed alternatives like fecal bacteria treatment. Prof. Nadir Arber and Dr. Maharshak Nitzan provide access to these specific protocols not yet standard globally.
Patient Consensus: Patients note that mesenchymal stem cell infusions at Hadassah Hospital have led to remission. Many highlight that fecal microbiota transplantation in Tel Aviv is more accessible than on international waitlists.
Surgery becomes necessary when biologics or immunosuppressants fail to control inflammation. In Israel, specialists perform colectomy to remove the diseased colon. This procedure is often curative. Patients transition to a surgical consult for reassessment. Diagnostic scans and blood work are updated before the operation.
Bookimed Expert Insight: While many focus on the surgery itself, the volume of procedures is the strongest quality signal in Israel. Assuta Medical Center performs over 92,000 operations annually. Facilities with such high surgical turnover often have more refined post-operative protocols. This volume typically leads to smoother transitions from intensive care to standard recovery wards.
Patient Consensus: Patients note that surgery feels like a step toward freedom rather than a failure of treatment. They emphasize that while a J-pouch requires a long adaptation period, the relief from chronic flares is life-altering.
Israel is home to world-renowned ulcerative colitis centers recognized for multidisciplinary care and pioneering research. Top facilities include Tel Aviv Sourasky Medical Center (Ichilov), Hadassah Medical Center, and Sheba Medical Center. These JCI-accredited institutions utilize advanced diagnostics, including genetic and microbial analysis, to personalize inflammatory bowel disease (IBD) treatment plans.
Bookimed Expert Insight: Patient volume serves as a critical quality indicator in Israel. Our data shows Hadassah and Sourasky serve 1,000,000 and 1,800,000 patients yearly, respectively. This high volume allows surgeons like Dr. Ron Greenberg to specialize intensely in colorectal procedures. Centers with these scales often provide specialized pediatric tracks, such as those led by Dr. Bentov Amir.
Patient Consensus: Patients note that while public centers offer top research-driven results, private options like Assuta are better for skipping long administrative queues. Many highlight the success of switching to biologics like Vedolizumab at major Jerusalem units after previous treatment failures.
Israel monitors ulcerative colitis using a digital-first approach that combines AI-driven analytics with molecular profiling. Specialists at centers like Sourasky Medical Center utilize centralized health databases. These systems track treatment efficacy through real-time laboratory integration and advanced imaging to detect flares before symptoms appear.
Bookimed Expert Insight: Our data shows a high concentration of gastroenterology expertise at Sourasky Medical Center. Professors there, like Dr. Nadir Arber and Dr. Oren Shibolet, bring over 30 and 50 years of experience respectively. This clinical depth allows for highly personalized monitoring plans. They often combine standard blood tests with gene therapy research and molecular profiling. This level of specialization is rare even in other top-tier medical hubs.
Patient Consensus: Patients note that monitoring in Israel is very thorough, often involving frequent blood tests and colonoscopies. Many recommend using home calprotectin kits when available to catch inflammation early and reduce hospital visits.